VistaGen TherapeuticsVTGN 
$3.651.39%24h
1.39%24h
Global rank21419
Market cap$25.40M
Change 7d10.94%
YTD Performance-27.72%
SP500 benchmarkUnderperform
P/E-0.43
P/S-111.76
Revenue-$227.30K
Earnings-$59.25M
Dividend yield-
Main Sector
Healthcare
Category
VistaGen Therapeutics (VTGN) Net Assets
VTGN Net Assets in 2023: $12.08M
As of 24 Aug 2024, VistaGen Therapeutics net assets is $12.08M, an decrease of -81.33% to 2022. Net assets are calculated as total assets minus total liabilities. This value represents the VistaGen Therapeutics overall net worth, providing an insight into company's financial health and stability. Net assets are a key indicator of a stock value, reflecting what it essentially owns minus what it owes.
VistaGen Therapeutics Net Assets History from 2019 to 2024
-
Value:-
VTGN Net Assets History by year
| Year | Net assets | Change |
|---|---|---|
| 2023 | $12.08M | -81.33% |
| 2022 | $64.72M | -29.64% |
| 2021 | $91.98M | -1705.38% |
| 2020 | $-5.73M | -96.84% |
| 2019 | $-181.09M | - |
View the Top Net Assets Companies
